Anteris Technologies Global (AVR) Non-Current Debt (2025 - 2026)
Anteris Technologies Global (AVR) posted quarterly Non-Current Debt of $18000.0 for Q1 2026, down 40.0% year-over-year from $30000.0 in Q1 2025, and down 18.18% quarter-over-quarter from $22000.0 in Q4 2025.
Anteris Technologies Global (AVR) Non-Current Debt (2025 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Non-Current Debt for 2 consecutive years, with $18000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt fell 40.0% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $18000.0 (down 40.0% YoY), while the FY2025 annual figure was $22000.0, changed N/A from the prior year.
- Non-Current Debt retreated to $18000.0 in Q1 2026 per AVR's latest filing, from $22000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $30000.0 in Q1 2025 and bottomed at $18000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Anteris Technologies Global | 902.34 Mn | 902.34 Mn | 776,000.00 | 47,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |